ZFIN ID: ZDB-FIG-200608-27
Tyrkalska et al., 2019 - Inflammasome Regulates Hematopoiesis through Cleavage of the Master Erythroid Transcription Factor GATA1. Immunity   51(1):50-63.e5 Full text @ Immunity
ADDITIONAL FIGURES
EXPRESSION / LABELING:
Antibodies:
Fish:
Condition:
Knockdown Reagent:
Anatomical Term:
Stage: Protruding-mouth
PHENOTYPE:
Fish:
Condition:
Knockdown Reagents:
Observed In:
Stage: Protruding-mouth

Fig. 7 ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

Gene Expression Details No data available
Antibody Labeling Details
Antibody Assay Fish Conditions Stage Anatomy
Ab2-gata1a WB mitfaw2/w2; mpv17a9/a9 chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Protruding-mouth whole organism
WB mitfaw2/w2; mpv17a9/a9 + MO2-gata1a control Protruding-mouth whole organism
WB mitfaw2/w2; mpv17a9/a9 + MO2-gata1a chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Protruding-mouth whole organism
Ab3-spi1 WB mitfaw2/w2; mpv17a9/a9 + MO2-gata1a control Protruding-mouth whole organism
WB mitfaw2/w2; mpv17a9/a9 + MO2-gata1a chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Protruding-mouth whole organism
Phenotype Details
Fish Conditions Stage Phenotype
c264Tg; sh267Tg chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Protruding-mouth neutrophil decreased amount, abnormal
mitfaw2/w2; mpv17a9/a9 chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Protruding-mouth whole organism Ab2-gata1a labeling increased amount, abnormal
mitfaw2/w2; mpv17a9/a9 + MO2-gata1a control Protruding-mouth nucleate erythrocyte decreased amount, abnormal
Protruding-mouth whole organism Ab2-gata1a labeling decreased amount, abnormal
Protruding-mouth whole organism Ab3-spi1 labeling increased amount, abnormal
mitfaw2/w2; mpv17a9/a9 + MO2-gata1a chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Protruding-mouth nucleate erythrocyte decreased amount, ameliorated
Protruding-mouth whole organism Ab2-gata1a labeling amount, ameliorated
Protruding-mouth whole organism Ab3-spi1 labeling amount, ameliorated
spint1ahi2217Tg/hi2217Tg control Protruding-mouth cysteine-type endopeptidase activity involved in apoptotic process increased occurrence, abnormal
spint1ahi2217Tg/hi2217Tg; c264Tg; sh267Tg control Protruding-mouth integument neutrophil increased amount, abnormal
Protruding-mouth neutrophil increased amount, abnormal
spint1ahi2217Tg/hi2217Tg; c264Tg; sh267Tg chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Protruding-mouth integument neutrophil increased amount, abnormal
Protruding-mouth neutrophil amount, ameliorated
spint1ahi2217Tg/hi2217Tg; c264Tg; sh267Tg + CRISPR4-caspa control Protruding-mouth neutrophil amount, ameliorated
Full text @ Immunity